Lv3
330 积分 2022-04-28 加入
Human Abl kinase domain in complex with imatinib (STI571, Glivec)
14天前
已关闭
Discovery of mobocertinib, a potent, oral inhibitor of EGFR exon 20 insertion mutations in non–small cell lung cancer
17天前
已完结
Discovery of mobocertinib, a potent, oral inhibitor of EGFR exon 20 insertion mutations in non–small cell lung cancer
17天前
已完结
BMN 673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency
17天前
已关闭
Abstract 3790: Preclinical profile of LGX818: A potent and selective RAF kinase inhibitor
18天前
已关闭
Preclinical discovery and clinical development of encorafenib for the treatment of melanoma
18天前
已完结
Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs
22天前
已完结
Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry
1个月前
已关闭
Development of Dihydroquinoxalinone-Based Dual CDK6/BET Inhibitors for Triple-Negative Breast Cancer Therapy
1个月前
已完结
Design and Development of DNA Damage Chemical Inducers of Proximity for Targeted Cancer Therapy
2个月前
已完结
皖公网安备34019202002308
